A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma

✍ Scribed by Richardson, PG; Lonial, S; Jakubowiak, A; Jagannath, S; Raje, N; Avigan, D; Ghobrial, IM; Schlossman, R; Mazumder, A; Munshi, NC; Vesole, D; Joyce, R; Doss, D; Warren, D; Lunde, L; Lukas, R; Kaster, S; Shea, K; Delaney, C; Lauria, M; Mitsiades, C; Hideshima, T; Knight, R; Esseltine, DL; Anderson, KC

• Book ID: 118629283
• Publisher: CIG Media Group, LP.
• Year: 2009
• Tongue: English
• Weight: 86 KB
• Volume: 9
• Category: Article
• ISSN: 1557-9190
• DOI: 10.1016/s1557-9190(11)70510-8